Indication
Liver cancer
5 clinical trials
10 products
1 drug
Clinical trial
A Phase 2, Randomized, Open-label Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Hepatocellular Carcinoma Who Are Naive to IO Therapy But Progressed on Tyrosine Kinase Inhibitors (RELATIVITY-073)Status: Active (not recruiting), Estimated PCD: 2023-08-31
Product
NivolumabProduct
RelatlimabClinical trial
A Phase 2 Study of SHR-1210 (PD-1 Antibody) in Combination With Apatinib or Chemotherapy (FOLFOX4 or GEMOX) in Subjects With Advanced Primary Liver Cancer（PLC）or Biliary Tract Carcinoma (BTC)Status: Completed, Estimated PCD: 2021-03-31
Product
SHR-1210Product
ApatinibProduct
FOLFOX4Product
GEMOXClinical trial
Functional Liver Imaging With Sulfur Colloid SPECT/CT in Primary and Metastatic Liver Cancer Patients Receiving Liver-Directed Treatment: A Pilot StudyStatus: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
Phase I/II Trial of Anti-CTLA4-NF mAb (BMS-986218) in Combination With Nivolumab and Hypofractionated Stereotactic Radiation Therapy in Patients With Advanced Solid MalignanciesStatus: Active (not recruiting), Estimated PCD: 2025-05-27
Product
BMS-986218Drug
T-VECClinical trial
Effects of Different Inhalational Anesthetic Agents on the Incidence of Clinical and Subclinical Acute Kidney Injury After Liver Resection Surgery: a Pilot StudyStatus: Withdrawn, Estimated PCD: 2023-05-01
Product
SevofluraneProduct
Desflurane